3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
3
Recruiting
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
525
Neoplasms
378
Prostatic Neoplasms
255
Colorectal Neoplasms
251
Lung Neoplasms
199
Carcinoma, Hepatocellular
177
Stomach Neoplasms
159
Pancreatic Neoplasms
151
Rectal Neoplasms
141
Colonic Neoplasms
125
Motor Activity
124
Carcinoma, Non-Small-Cell Lung
115
Uterine Cervical Neoplasms
112
Head and Neck Neoplasms
96
Polycystic Ovary Syndrome
94
Esophageal Neoplasms
90
Neoplasm Metastasis
69
Brain Neoplasms
69
Liver Neoplasms
67
Ovarian Neoplasms
65
Recurrence
60
Urinary Bladder Neoplasms
58
Fatigue
55
Pain
54
Lymphoma
53
Endometrial Neoplasms
51
Thyroid Neoplasms
47
Melanoma
47
Anxiety Disorders
47
Pain, Postoperative
41
Interventions
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Unknown
×
Hyperaldosteronism
×
Clear all
NCT02030587
2017-04-25
LARFA
Chinese University of Hong Kong
Phase NA
Unknown
36 enrolled